Chicken IFN-gamma (Interferon Gamma) ELISA Kit
Referencia MBS2503559-96
embalaje : 96Tests
Marca : MyBiosource
IFN-Gamma ELISA Kit for Chicken
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2503559SPECIAL PROMOTIONAL PRICING for a limited time
Principle of the Assay: This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Chicken IFN-gamma. Samples (or Standards) are added to the micro ELISA plate wells and… More details
Product Overview
Online Datasheet in PDFProduct Name
IFN-gamma, ELISA Kit
Full Product Name
Chicken IFN-gamma (Interferon Gamma) ELISA Kit
Product Gene Name
IFN-gamma elisa kit
Species Reactivity
Chicken
Assay Type
Quantitative Sandwich
Samples
Serum, plasma and other biological fluids
Detection Range
15.63-1000 pg/mL
Sensitivity
9.38 pg/mL
Specificity
This kit recognizes Chicken IFN-gamma in samples. No significant cross-reactivity or interference between Chicken IFN-gamma and analogues was observed
Preparation and Storage
Store at 4 degree C.
Inter-assay Precision
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Chicken IFN-gamma were tested on 3 different plates, 20 replicates in each plate, respectively.
Intra-assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Chicken IFN-gamma were tested 20 times on one plate, respectively.
Molecular Weight
19,348 Da
OMIM
147570
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of IFN-gamma elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for IFN-gamma purchase
MBS2503559 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the IFN-gamma, ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing IFN-gamma. The ELISA analytical biochemical technique of the MBS2503559 kit is based on IFN-gamma antibody-IFN-gamma antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect IFN-gamma antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, IFN-gamma. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
Additional Details
NCBI/Uniprot data below describe general gene information for IFN-gamma. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
interferon gamma
NCBI Official Synonym Full Names
interferon, gamma
NCBI Official Symbol
IFNG
NCBI Official Synonym Symbols
IFG; IFI
UniProt Protein Name
Interferon gamma
UniProt Synonym Protein Names
Immune interferon
Protein Family
Interferon gamma receptor
UniProt Gene Name
IFNG
UniProt Synonym Gene Names
IFN-gamma
UniProt Entry Name
IFNG_HUMAN
NCBI Protein Information
interferon gamma; IFN-gamma; immune interferon
NCBI Summary for IFN-gamma
This gene encodes a member of the type II interferon family. The protein encoded is a soluble cytokine with antiviral, immunoregulatory and anti-tumor properties and is a potent activator of macrophages. Mutations in this gene are associated with aplastic anemia.[provided by RefSeq, Nov 2009]
UniProt Comments for IFN-gamma
IFNG: Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. Homodimer. Released primarily from activated T lymphocytes. Belongs to the type II (or gamma) interferon family.
Protein type: Secreted; Membrane protein, integral; Cytokine; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 12q14
Cellular Component: extracellular space; extracellular region; external side of plasma membrane
Molecular Function: interferon-gamma receptor binding; cytokine activity
Biological Process: positive regulation of isotype switching to IgG isotypes; positive regulation of nitric oxide biosynthetic process; positive regulation of interleukin-12 production; apoptosis; negative regulation of smooth muscle cell proliferation; positive regulation of osteoclast differentiation; positive regulation of interleukin-23 production; positive regulation of interleukin-6 biosynthetic process; negative regulation of epithelial cell differentiation; positive regulation of killing of cells of another organism; sensory perception of mechanical stimulus; positive regulation of interleukin-1 beta secretion; negative regulation of transcription from RNA polymerase II promoter; positive regulation of membrane protein ectodomain proteolysis; cell surface receptor linked signal transduction; positive regulation of MHC class II biosynthetic process; positive regulation of cell proliferation; positive regulation of mesenchymal cell proliferation; positive regulation of T cell proliferation; cell cycle arrest; defense response to virus; regulation of the force of heart contraction; positive regulation of peptidyl-serine phosphorylation of STAT protein; response to drug; neutrophil chemotaxis; positive regulation of synaptic transmission, cholinergic; adaptive immune response; negative regulation of myelination; CD8-positive, alpha-beta T cell differentiation during immune response; unfolded protein response; cytokine and chemokine mediated signaling pathway; response to virus; defense response to protozoan; positive regulation of tumor necrosis factor production; humoral immune response; antigen processing and presentation; positive regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of interleukin-17 production; positive regulation of chemokine biosynthetic process; positive regulation of interleukin-12 biosynthetic process; protein import into nucleus, translocation; defense response to bacterium; neutrophil apoptosis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of neuron differentiation; cell motility; regulation of insulin secretion
Disease: Hepatitis C Virus, Susceptibility To; Aplastic Anemia; Mycobacterium Tuberculosis, Susceptibility To; Tuberous Sclerosis 2; Human Immunodeficiency Virus Type 1, Susceptibility To
Show more Protein type: Secreted; Membrane protein, integral; Cytokine; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 12q14
Cellular Component: extracellular space; extracellular region; external side of plasma membrane
Molecular Function: interferon-gamma receptor binding; cytokine activity
Biological Process: positive regulation of isotype switching to IgG isotypes; positive regulation of nitric oxide biosynthetic process; positive regulation of interleukin-12 production; apoptosis; negative regulation of smooth muscle cell proliferation; positive regulation of osteoclast differentiation; positive regulation of interleukin-23 production; positive regulation of interleukin-6 biosynthetic process; negative regulation of epithelial cell differentiation; positive regulation of killing of cells of another organism; sensory perception of mechanical stimulus; positive regulation of interleukin-1 beta secretion; negative regulation of transcription from RNA polymerase II promoter; positive regulation of membrane protein ectodomain proteolysis; cell surface receptor linked signal transduction; positive regulation of MHC class II biosynthetic process; positive regulation of cell proliferation; positive regulation of mesenchymal cell proliferation; positive regulation of T cell proliferation; cell cycle arrest; defense response to virus; regulation of the force of heart contraction; positive regulation of peptidyl-serine phosphorylation of STAT protein; response to drug; neutrophil chemotaxis; positive regulation of synaptic transmission, cholinergic; adaptive immune response; negative regulation of myelination; CD8-positive, alpha-beta T cell differentiation during immune response; unfolded protein response; cytokine and chemokine mediated signaling pathway; response to virus; defense response to protozoan; positive regulation of tumor necrosis factor production; humoral immune response; antigen processing and presentation; positive regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of interleukin-17 production; positive regulation of chemokine biosynthetic process; positive regulation of interleukin-12 biosynthetic process; protein import into nucleus, translocation; defense response to bacterium; neutrophil apoptosis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of neuron differentiation; cell motility; regulation of insulin secretion
Disease: Hepatitis C Virus, Susceptibility To; Aplastic Anemia; Mycobacterium Tuberculosis, Susceptibility To; Tuberous Sclerosis 2; Human Immunodeficiency Virus Type 1, Susceptibility To
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with IFN-gamma elisa kit
| Reference Product | PubMed Publications |
|---|---|
| CD4 elisa kit | >153 publications with IFN-gamma and CD4 |
| IL2 elisa kit | >58 publications with IFN-gamma and IL2 |
| TBX21 elisa kit | >53 publications with IFN-gamma and TBX21 |
| STAT1 elisa kit | >39 publications with IFN-gamma and STAT1 |
| IFNGR1 elisa kit | >31 publications with IFN-gamma and IFNGR1 |
| IL18 elisa kit | >23 publications with IFN-gamma and IL18 |
| IRF1 elisa kit | >16 publications with IFN-gamma and IRF1 |
| CD86 elisa kit | >6 publications with IFN-gamma and CD86 |
Pathways associated with IFN-gamma elisa kit
| Products by Pathway | Pathway Diagram |
|---|---|
| ATF-2 Transcription Factor Network Pathway antibodies | ATF-2 Transcription Factor Network Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| Allograft Rejection Pathway antibodies | Allograft Rejection Pathway Diagram |
| Allograft Rejection Pathway antibodies | Allograft Rejection Pathway Diagram |
| Allograft Rejection Pathway antibodies | Allograft Rejection Pathway Diagram |
| Amoebiasis Pathway antibodies | Amoebiasis Pathway Diagram |
| Amoebiasis Pathway antibodies | Amoebiasis Pathway Diagram |
| Antigen Processing And Presentation Pathway antibodies | Antigen Processing And Presentation Pathway Diagram |
| Antigen Processing And Presentation Pathway antibodies | Antigen Processing And Presentation Pathway Diagram |
Diseases associated with IFN-gamma elisa kit
| Disease Name | Pubmed Publications |
|---|---|
| Necrosis Antibodies | >150 publications with IFN-gamma and Necrosis |
| Autoimmune Diseases Antibodies | >87 publications with IFN-gamma and Autoimmune Diseases |
| Respiratory Tract Diseases Antibodies | >70 publications with IFN-gamma and Respiratory Tract Diseases |
| Hepatitis Antibodies | >33 publications with IFN-gamma and Hepatitis |
| Lymphoproliferative Disorders Antibodies | >21 publications with IFN-gamma and Lymphoproliferative Disorders |
| Diabetes Mellitus, Type 1 Antibodies | >17 publications with IFN-gamma and Diabetes Mellitus, Type 1 |
| HIV Infections Antibodies | >17 publications with IFN-gamma and HIV Infections |
| Hepatitis C Antibodies | >15 publications with IFN-gamma and Hepatitis C |
| Arthritis, Rheumatoid Antibodies | >15 publications with IFN-gamma and Arthritis, Rheumatoid |
| Leishmaniasis Antibodies | >11 publications with IFN-gamma and Leishmaniasis |
Organs/Tissues associated with IFN-gamma elisa kit
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >483 publications with IFN-gamma and Blood |
| Kidney Antibodies | >42 publications with IFN-gamma and Kidney |
| Lymph Node Antibodies | >26 publications with IFN-gamma and Lymph Node |
Usted podría estar interesado también en los siguientes productos:
Referencia
Descripción
Cond.
Precio Sin IVA


